Introduction
Assessing visual health is a fundamental goal of ophthalmic practice. How one defines visual health has important implications for how it is measured and appraised. While the definition of health is subject to extensive debate, most individuals can agree that health involves the ability of an individual to perform common activities essential to modern life. Indeed, few would contest the idea that one lacks some measure of health if they are unable to perform essential activities of daily living such as walking, recognizing friendly faces and finding dropped items. While these ideas seem self-evident, the assessment of one's ability to perform activities of daily living is rarely used to assess visual health.
Traditional assessments of vision typically involve four types of information: 1) symptoms acquired through a medical history; 2) signs obtained through physical examination; 3) laboratory data; and 4) anatomic data acquired through various imaging modalities. Importantly, the advancement of modern biotechnology has provided novel methods of technology-intensive evaluations in the form of more sensitive imaging and laboratory assessments of visual health, such as confocal scanning laser ophthalmoscopy, optical coherence tomography and genetic analysis. However, it is evident that the results of these high-technology assessments are often unrelated to one's ability to carry out daily activities. The disjunction between the current trend of high-technology assessment and the ability to function at a practical level is representative of the often encountered discrepancy between what is important to clinicians and what is important to patients.
Over the last decade the discipline of visual health sciences has seen the growing use of standardized medical histories in the form of quality of life (QoL) questionnaires to evaluate the health of the visual system. This trend can be viewed, at least in part, as a means with which to address the discordance between high-technology disease assessment and its associated lack of focus on what is practically important to patients. While the growing use of vision-specific QoL surveys has provided important information about the impact of visual disease from a patient's perspective, this modality of evaluation comes with its own range of limitations. Health-related QoL surveys, including vision-specific questionnaires, are influenced by a very broad range of factors including patient personality, individual preferences, personal biases, mental health, desire to mislead and desire to please. [1] [2] [3] [4] [5] [6] In an effort to 4/22
develop new methods of assessing the visual health of patients, several investigators have developed and tested standardized protocols that evaluate the ability of individuals to perform visually-intensive daily activities. Although the content of these different investigative techniques tend to vary in the specific activities tested, they all have a common focus on detecting changes in very basic and practical visual abilities required to perform daily activities. The results of these studies have demonstrated that performance-based measures (PBMs) of visual function are valid and reliable measures of visual health. [7] [8] [9] [10] [11] In the same tradition of research, the investigation presented here is intended to validate a thirdgeneration PBM of visual function titled the "Assessment of Disability Related to Vision" (ADREV) in a population of individuals with diabetic retinopathy.
Methods
Study participants were selected chronologically from individuals receiving care within the general ophthalmology clinics and private practices of retinal-vitreous specialists at Wills Eye Institute. Inclusion/ exclusion criteria included a diagnosis of either non-proliferative or proliferative diabetic retinopathy (DR), written and verbal English proficiency, no visually significant ocular comorbidity and no active visual rehabilitation treatments at the time of study participation. Cataract assessment was made using the Lens Opacities Classification System II (LOCS II) with exclusion of patients with a 2+ cataract in any category. 12 Study participants were not to have had retinal photocoagulation treatments within one month of study participation. Individuals with medical comorbidities that resulted in significant neurological or other systemic manifestations that would have prevented them from completing the study's protocol were also excluded. Patients were selected to reflect a broad range of visual impairment based on better eye visual acuity and were identified using a process that included a medical chart review and brief interview.
All prospective patients were fully informed regarding the details of the study and those who agreed to participate completed an informed consent process which was approved by the Wills Eye Institute 13 Finally, demographic data was collected using a standard form and included age, gender, ethnicity and medical comorbidities.
The ADREV instrument is based on a prior investigation involving an alternative PBM titled the Assessment of Function Related to Vision (AFREV). 14 15 The ADREV is comprised of 9 tests including: 1) Reading in Reduced Illumination, 2) Facial represents the inability to perform the test and 7 indicates a perfect score. In addition to the subscale evaluations, the nine tests are summed to produce an ADREV total score ranging from 0 -63. The subscales can be employed and interpreted independently from the ADREV total score. Average test administration time, including patient instruction is approximately 30 minutes. The ADREV has been previously validated in a study population involving patients with age-related macular degeneration through comparison with standard clinical measures of visual function and self-reported QoL. 16 
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The VFQ was selected as the study's primary QoL measurement as it is accepted as a reliable and valid means of studying the self-perceived impact of visual impairment upon vision-specific QoL. [17] [18] [19] The VFQ is a generic vision-specific instrument that was designed to study a wide variety of ocular diseases and a number of studies have used the VFQ to study the self-reported QoL of patients with DR. [18] [19] [20] [21] [22] The 25-item VFQ is comprised of eleven vision-specific subscales that address the following domains: 1) general vision, 2) near vision, 3) distance vision, 4) ocular pain, 5) social functioning, 6) mental health, 7) role difficulties, 8) dependency, 9) driving, 10) color vision and 11) peripheral vision. Each subscale is scored from 0 -100, where 100 represents self-perceived perfect functioning and 0 represents the greatest level of difficulty in a given domain. The eleven subscales are also averaged to produce a VFQ total score ranging from 0 -100. The average test administration time for the VFQ is approximately 10 minutes.
Data analysis was conducted in several steps. First, all variables were plotted and reviewed for outliers that might represent data entry errors. Descriptive statistics were computed for demographic, past medical, clinical ophthalmic, QoL and PBM measures. Independent t tests were used to determine if any differences existed in average VFQ and ADREV total and subscale scoring based on dichotomous demographics. Analysis of variance (ANOVA) was conducted to identify statistically significant differences in mean VFQ and ADREV total and subscale scores with respect to categorical variables that lacked an inherent conceptual hierarchy. Spearman's rho was used to determine correlative relationships between the study's clinical variables and both the VFQ and ADREV total and subscale scores, as well as between the VFQ and ADREV total and subscale scores. Spearman's nonparametric statistic was chosen to standardize comparisons as selected portions of the data provided by the VFQ total and subscale scores do not meet the requirements of interval variables. 23, 24 Correlation coefficients (r) were considered small if less than 0.3, medium between 0.3 and 0.5 and large if greater than 0.5. 25 In addition, a robust regression analysis using Huber's Method was used to determine the clinical measures that are most associated with each of the ADREV total and subscale scores, while controlling for age, gender, ethnicity and total number of medical comorbidities. 24 This approach was chosen for several reasons. Robust regression is a valid statistical method for data that meet the criteria for analysis with ordinary least squares regression (OLS); however, it is also resistant to the effects of data outliers and can analyze non-
normally distributed, categorical and binary data. 26, 27 All variables were entered into the regression equations simultaneously and no automated variable selection process was utilized. Prior to regression equation construction, a correlation matrix using Spearman's rho was completed using all of the study's independent and control variables to identify and exclude collinear relationships from the regression analysis based on correlations of r >/= 0.9. 28 Scatterplots were constructed between the measures of clinical ophthalmic status and the ADREV total and subscale scores in order to detect any non-linear relationships. Independent and control variables were entered into the regression equation irrespective of the presence or absence of significant bivariate relationships with ADREV total or subscale scoring. In keeping with accepted statistical practice, the number of independent and control variables included in each regression equation was equal to or less than 1/10 the total number of cases in our sample population. 29 Residual statistics for each regression equation were plotted to identify highly significant outliers that might have compromised the explanatory power of each regression equation. A supplementary bootstrap analysis of 1,000 random resampled data sets was conducted to test the external validity of the relationships identified during initial regression modeling. [30] [31] [32] Where appropriate, all statistical tests were run in a two-tailed fashion and corrections for multiple comparisons were made using the Bonferroni method. 33 A power analysis based on the effect sizes noted in the AFREV experiment indicated that a sample population of 90 individuals would be adequate to detect an r = 0.3 with 80% power and α = 0.05.
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Results
Our Bivariate analysis between the study's' clinical variables and the ADREV total and subscale measures demonstrated that 53 of the total 60 (88%) comparisons were significant to p < 0.05 (Table II) . After adjustment for multiple comparisons, 49 of the 60 comparisons (82%) were statistically significant to p < 0.0007 (Table II) 
Discussion
This study had several limitations. To begin, all individuals were recruited from a single tertiary ophthalmic hospital and it may not be possible to validly generalize our findings to all individuals. Study participants completed approximately two hours of testing as part of the study protocol and fatigue may have influenced the results of our testing. Indicators of clinical depression were not collected and individuals suffering from clinical depression may have influenced the reported scores on the VFQ. 3, 35 The study population size was also limited to ninety one individuals and it is possible that additional, weaker relationships were not detected. Our inclusion/ exclusion criteria removed all individuals with ocular comorbidity, as well as any serious musculoskeletal or neurological impairment that might have influenced their testing results and this may limit the applicability of our results to all patient subpopulations. Furthermore, other clinical measures of visual function such as stereopsis, glare testing and color vision were not completed by the study population and there may be additional associations between these measures and the ADREV that were not measured by this investigation. It should also be acknowledged that while the activities chosen for the ADREV are commonly encountered in daily living, not all individuals will perform these activities or value them to the same extent. Others have elected to have patients weigh the importance of each activity used in performance testing and this approach could be employed to improve future versions of the ADREV. 36 Despite these potential limitations, the results of our investigation support the validity of the ADREV and subscale scoring, after controlling for age, gender, ethnicity and medical comorbidity. Importantly, however, while the relationships noted between traditional measures of ophthalmic status and the ADREV were large in magnitude, they were not large enough to validly infer that traditional ophthalmic measures can be used as surrogates for the evaluations provided by the ADREV. Though highly related, the moderate to strong relationships noted in this study between traditional clinical measures of visual function and ADREV performance provide support to the notion that measurements of actual patient performance provide qualitatively different information than surrogate measures of functional performance such as visual acuity, contrast sensitivity or visual field measurements.
All of the relationships fit well with our current understanding of the types of visual abilities affected by patients with DR. The role of better eye visual field in the ability to correctly match socks from a presented selection likely relates to the ability to simultaneously survey several different items in order to correctly match similar items. Individuals with "tunnel vision" due to a constricted visual field would be less able to simultaneously compare the visual qualities of multiple items that need to be viewed across a larger expanse of visual field. The importance of central visual acuity in reading, facial recognition, reading street signs and dialing a telephone is readily apparent. Similarly, the relationship found between better eye visual field and motion detection is well supported by prior research. 37 The role of contrast sensitivity appeared important when performing a number of different activities. Contrast sensitivity proved to be related to the ability to discern significant detail, including facial expression recognition and placing a peg into a small hole; yet also had an important association with the ability to locate objects in a room. These findings are consistent with the types of visual loss that patients with DR often experience related to not only the natural history of the disease, but also to the reduction in peripheral vision associated with retinal photocoagulation used to preserve central visual function. These findings emphasize the multi-faceted nature of the visual abilities required to function in day to day living and the many different visual challenges faced by patients with DR.
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In comparison to the previous investigation involving the ADREV and patients with AMD we noted similar absolute mean correlative bivariate relationships between the ADREV total and subscale scores and clinic measures of visual function (DR r = 0.515, AMD r = 0.569). 16 d. All patients were fully informed regarding the details of the study and those who agreed to participate completed an informed consent process which was approved by the Wills Eye Institute Institutional Review Board (IRB) and in compliance with the Declaration of Helsinki. *Independent variables presented are significant to p </ = 0.05 after controlling for age, gender, ethnicity and no. of medical comorbidities. † Estimates made using a resampling of 1,000 random data sets and displayed variables are significant within 95% confidence intervals. 
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Reading in reduced illumination
Near vision is checked by obtaining the smallest Jaeger line, then one at a time, 7 sentences, text size corresponding to 2 Jaeger lines above the smallest Jaeger read, are presented. Light illumination is reduced after each sentence is read. The corresponding score is as follows: 1 point, able to read at 200 foot candles (FC), 2 at 150 FC, 3 at 100 FC, 4 at 50 FC, 5 at 25 FC, 6 at 10 FC and 7 at 5 FC. The highest score is 7 and lowest score is 0.
Facial expression recognition
Seven full-face professional, colored photos of varying sizes and facial expressions (angry, sad, happy, or surprised) are presented on a computer screen at a distance of 1/2 meter. The patient receives one point for recognizing the right facial expression. Score ranged from 7 to 0.
Computerized Motion Detection
A large black cross against a white background on a computer screen provides a point of fixation. While fixating on the cross, one at a time, 14 balls of different sizes and colors move diagonally across the screen from either the right or the left side at a constant speed. Yellow, red, or blue balls are used. The patient is asked to count the number of moving balls. Each ball seen counts as ½ point. Highest score is 7 and lowest score is 0.
Recognizing street signs
Seven written word signs ranging from large to small are read at a distance of 4 meters. One character in each sign, was changed from familiar phrases making the word difficult to guess. For example, the top sign reads SUGAR DANE, which is similar to the more familiar sugar cane. The patient is instructed not to guess. One point is given for each sign read correctly. Highest score is 7 and lowest score is 0.
Locating objects
Fourteen red and beige boxes of different sizes are scattered around the testing room (4 x 2 meters). Sample boxes are shown before test started. The patient attempts to locate the boxes while seated. Each box found is worth ½ point. Highest score will be 7 and lowest 0.
6. Ambulation test A 4.5 meter predefined mobility course was designed, with taped horizontal, vertical and diagonal lines and objects made of styrofoam in the path. Several objects were also suspended from the ceiling along the path. Patients were permitted to use a mobility aid (e.g. cane). The score is based on number of obstacles hit. Each obstacle successfully avoided was awarded 1/3 point. The highest score is 7 and lowest is 0.
7. Placing a peg into different sized holes Seven (9x3x3/8 inches) wooden boards were created with 1 hole of varying sizes and location. A wooden stand was created with slots to hold the boards one at time at different angles. The patient is asked to place the peg directly in the hole without touching the board. One point is awarded for successful completion.
Telephone simulation
Seven calculators of different sizes are used to simulate dialing a telephone. The numbers are randomly rearranged to eliminate memory being used to locate the telephone numbers. The numbers are printed from different font sizes and presented to patients from largest to smallest. The patient is asked to press seven different numbers on each of the various sized calculators. The patient must find all seven numbers to receive a point for that calculator. For each number correctly "dialed", the patient receives one point. The highest score is 7 and lowest 0.
Matching socks
Seven differently patterned, dark-colored socks were hung on a board with a grey background. The patients are not permitted to touch the socks hanging on the wall. The patient sits in front of a table 1 
